» Articles » PMID: 36076273

Apoptosis Evasion Via Long Non-coding RNAs in Colorectal Cancer

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2022 Sep 8
PMID 36076273
Authors
Affiliations
Soon will be listed here.
Abstract

Long non-coding RNA (LncRNA) is a novel and diverse class of regulatory transcripts that are frequently dysregulated in numerous tumor types. LncRNAs are involved in a complicated molecular network, regulating gene expression, and modulating diverse cellular activities in different cancers including colorectal cancer (CRC). Evidence indicates that lncRNAs can be used as a potential biomarker for the prognosis and diagnosis of CRC as they are aberrantly expressed in CRC cells. The high expression or silencing of lncRNAs is associated with cell proliferation, invasion, metastasis, chemoresistance and apoptosis in CRC. LncRNAs exert both pro-apoptotic and anti-apoptotic functions in CRC. The expression of some oncogene lncRNAs is upregulated which leads to the inhibition of apoptotic pathways, similarly, the tumor suppressor lncRNAs are downregulated in CRC. In this review, we describe the function and mechanisms of lncRNAs to regulate the expression of genes that are involved directly or indirectly in controlling cellular apoptosis in CRC. Furthermore, we also discussed the different apoptotic pathways in normal cells and the mechanisms by which CRC evade apoptosis.

Citing Articles

Triptolide induces immunogenic cell death in cervical cancer cells via ER stress and redox modulation.

Zheng Z, Chen Y, Wang C, Li L, Tan B Am J Cancer Res. 2025; 15(1):69-83.

PMID: 39949945 PMC: 11815369. DOI: 10.62347/XNVR3799.


Long non-coding RNAs (lncRNAs) in cancer development: new insight from STAT3 signaling pathway to immune evasion.

Ma L, Liu X, Roopashree R, Kazmi S, Jasim S, Phaninder Vinay K Clin Exp Med. 2025; 25(1):53.

PMID: 39932585 PMC: 11813976. DOI: 10.1007/s10238-024-01532-8.


Crosstalk between non-coding RNAs and programmed cell death in colorectal cancer: implications for targeted therapy.

Taha S, Karimi M, Mahdavi B, Yousefi Tehrani M, Bemani A, Kabirian S Epigenetics Chromatin. 2025; 18(1):3.

PMID: 39810224 PMC: 11734566. DOI: 10.1186/s13072-024-00560-8.


Updated aspects of alpha-Solanine as a potential anticancer agent: Mechanistic insights and future directions.

Nandi S, Sikder R, Nag A, Khatua S, Sen S, Chakraborty N Food Sci Nutr. 2024; 12(10):7088-7107.

PMID: 39479710 PMC: 11521658. DOI: 10.1002/fsn3.4221.


Advancements in long non-coding RNA-based therapies for cancer: targeting, delivery, and clinical implications.

Ammad M, Javed Z, Sadia H, Ahmed R, Akbar A, Nadeem T Med Oncol. 2024; 41(11):292.

PMID: 39428417 DOI: 10.1007/s12032-024-02534-y.


References
1.
Byun D, Cho K, Ryu B, Lee M, Kang M, Kim H . Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas. Cancer Res. 2003; 63(21):7068-75. View

2.
Horak P, Pils D, Haller G, Pribill I, Roessler M, Tomek S . Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer. Mol Cancer Res. 2005; 3(6):335-43. DOI: 10.1158/1541-7786.MCR-04-0136. View

3.
Yang Y, Junjie P, Sanjun C, Ma Y . Long non-coding RNAs in Colorectal Cancer: Progression and Future Directions. J Cancer. 2017; 8(16):3212-3225. PMC: 5665037. DOI: 10.7150/jca.19794. View

4.
Lian Y, Yan C, Xu H, Yang J, Yu Y, Zhou J . A Novel lncRNA, LINC00460, Affects Cell Proliferation and Apoptosis by Regulating KLF2 and CUL4A Expression in Colorectal Cancer. Mol Ther Nucleic Acids. 2018; 12:684-697. PMC: 6083012. DOI: 10.1016/j.omtn.2018.06.012. View

5.
Cabanski C, White N, Dang H, Silva-Fisher J, Rauck C, Cicka D . Pan-cancer transcriptome analysis reveals long noncoding RNAs with conserved function. RNA Biol. 2015; 12(6):628-42. PMC: 4615893. DOI: 10.1080/15476286.2015.1038012. View